Biomind Labs Inc. (NEO: BMND | OTC: BMNDF | FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat...
The article PharmaTher Provides Year-End Highlights and Financials was originally published on Microdose. For more on PharmaTher check out PharmaTher...
The article Atai Life Sciences Launches Phase 1 MDMA Trial was originally published on Microdose. “We continue to execute on our pipeline – having...
The first thing anyone should know about psychedelic stocks is that it is a long game. If you are expecting a quick turn in profit for...
Genetics can influence every area of our biology, including how we respond to psychedelics. Understanding the roles that our genes play is essential when...
Genetics can influence every area of our biology, including how we respond to psychedelics. Understanding the roles that our genes play is essential when...
In the Phase II VISIONARY-MS trial (NCT03536559), which evaluated CNM-Au8 in participants with stable relapsing remitting multiple sclerosis (RRMS), CNM-Au8...
Existing treatments for fibromyalgia have limited efficacy. The post Tryp Looks at Patent for Psilocybin to Treat Fibromyalgia appeared first on Green...
The company is also spending big bucks for its media outreach. The post Oregon’s Silo Wellness Buys Dyscovry Science To Aid Psychedelic Retreats appeared...
The article News You Might Have Missed: Sep 26th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...